nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Methylprednisolone—psoriatic arthritis	0.202	0.248	CbGbCtD
Avanafil—CYP3A4—Triamcinolone—psoriatic arthritis	0.153	0.188	CbGbCtD
Avanafil—CYP3A4—Betamethasone—psoriatic arthritis	0.131	0.161	CbGbCtD
Avanafil—CYP3A4—Prednisolone—psoriatic arthritis	0.129	0.159	CbGbCtD
Avanafil—CYP3A4—Prednisone—psoriatic arthritis	0.122	0.15	CbGbCtD
Avanafil—CYP3A4—Dexamethasone—psoriatic arthritis	0.0763	0.0938	CbGbCtD
Avanafil—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.00767	0.0413	CcSEcCtD
Avanafil—Sinus congestion—Triamcinolone—psoriatic arthritis	0.00428	0.023	CcSEcCtD
Avanafil—Haematuria—Auranofin—psoriatic arthritis	0.00387	0.0208	CcSEcCtD
Avanafil—Eye disorder—Auranofin—psoriatic arthritis	0.00341	0.0183	CcSEcCtD
Avanafil—Oropharyngeal pain—Triamcinolone—psoriatic arthritis	0.00234	0.0126	CcSEcCtD
Avanafil—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.00231	0.0124	CcSEcCtD
Avanafil—Dyspepsia—Auranofin—psoriatic arthritis	0.00228	0.0123	CcSEcCtD
Avanafil—Constipation—Auranofin—psoriatic arthritis	0.00221	0.0119	CcSEcCtD
Avanafil—Wheezing—Triamcinolone—psoriatic arthritis	0.00207	0.0111	CcSEcCtD
Avanafil—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.00193	0.0104	CcSEcCtD
Avanafil—Pruritus—Auranofin—psoriatic arthritis	0.00183	0.00985	CcSEcCtD
Avanafil—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.00178	0.00955	CcSEcCtD
Avanafil—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.00177	0.00953	CcSEcCtD
Avanafil—Diarrhoea—Auranofin—psoriatic arthritis	0.00177	0.00953	CcSEcCtD
Avanafil—Vomiting—Auranofin—psoriatic arthritis	0.00165	0.00886	CcSEcCtD
Avanafil—Rash—Auranofin—psoriatic arthritis	0.00163	0.00878	CcSEcCtD
Avanafil—Dermatitis—Auranofin—psoriatic arthritis	0.00163	0.00877	CcSEcCtD
Avanafil—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.00161	0.00867	CcSEcCtD
Avanafil—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.00161	0.00867	CcSEcCtD
Avanafil—Nausea—Auranofin—psoriatic arthritis	0.00154	0.00827	CcSEcCtD
Avanafil—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00149	0.00799	CcSEcCtD
Avanafil—Diabetes mellitus—Prednisone—psoriatic arthritis	0.0014	0.00755	CcSEcCtD
Avanafil—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00139	0.00749	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00136	0.00731	CcSEcCtD
Avanafil—Influenza—Triamcinolone—psoriatic arthritis	0.00133	0.00718	CcSEcCtD
Avanafil—Weight increased—Prednisolone—psoriatic arthritis	0.00132	0.00711	CcSEcCtD
Avanafil—Bronchitis—Triamcinolone—psoriatic arthritis	0.00128	0.00691	CcSEcCtD
Avanafil—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00124	0.00667	CcSEcCtD
Avanafil—Weight increased—Triamcinolone—psoriatic arthritis	0.00121	0.00654	CcSEcCtD
Avanafil—Weight increased—Methylprednisolone—psoriatic arthritis	0.00121	0.00652	CcSEcCtD
Avanafil—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00119	0.00639	CcSEcCtD
Avanafil—Infestation—Methylprednisolone—psoriatic arthritis	0.00119	0.00639	CcSEcCtD
Avanafil—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.00117	0.00631	CcSEcCtD
Avanafil—Epistaxis—Triamcinolone—psoriatic arthritis	0.00112	0.00604	CcSEcCtD
Avanafil—Weight increased—Dexamethasone—psoriatic arthritis	0.0011	0.00593	CcSEcCtD
Avanafil—Weight increased—Betamethasone—psoriatic arthritis	0.0011	0.00593	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00108	0.00579	CcSEcCtD
Avanafil—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00105	0.00564	CcSEcCtD
Avanafil—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000996	0.00536	CcSEcCtD
Avanafil—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000989	0.00532	CcSEcCtD
Avanafil—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000967	0.0052	CcSEcCtD
Avanafil—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000963	0.00518	CcSEcCtD
Avanafil—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000961	0.00517	CcSEcCtD
Avanafil—Weight increased—Prednisone—psoriatic arthritis	0.00096	0.00516	CcSEcCtD
Avanafil—Vision blurred—Prednisolone—psoriatic arthritis	0.000953	0.00513	CcSEcCtD
Avanafil—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000934	0.00502	CcSEcCtD
Avanafil—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000928	0.00499	CcSEcCtD
Avanafil—Breast disorder—Methotrexate—psoriatic arthritis	0.000922	0.00496	CcSEcCtD
Avanafil—Vertigo—Prednisolone—psoriatic arthritis	0.000909	0.00489	CcSEcCtD
Avanafil—Eye disorder—Dexamethasone—psoriatic arthritis	0.000906	0.00487	CcSEcCtD
Avanafil—Eye disorder—Betamethasone—psoriatic arthritis	0.000906	0.00487	CcSEcCtD
Avanafil—Back pain—Triamcinolone—psoriatic arthritis	0.0009	0.00484	CcSEcCtD
Avanafil—Angiopathy—Dexamethasone—psoriatic arthritis	0.00088	0.00473	CcSEcCtD
Avanafil—Angiopathy—Betamethasone—psoriatic arthritis	0.00088	0.00473	CcSEcCtD
Avanafil—Hypertension—Prednisolone—psoriatic arthritis	0.000873	0.0047	CcSEcCtD
Avanafil—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000845	0.00455	CcSEcCtD
Avanafil—Vertigo—Triamcinolone—psoriatic arthritis	0.000836	0.0045	CcSEcCtD
Avanafil—Vertigo—Methylprednisolone—psoriatic arthritis	0.000834	0.00449	CcSEcCtD
Avanafil—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00083	0.00446	CcSEcCtD
Avanafil—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000819	0.00441	CcSEcCtD
Avanafil—Cough—Triamcinolone—psoriatic arthritis	0.000812	0.00437	CcSEcCtD
Avanafil—Tachycardia—Prednisolone—psoriatic arthritis	0.000806	0.00433	CcSEcCtD
Avanafil—Hypertension—Triamcinolone—psoriatic arthritis	0.000803	0.00432	CcSEcCtD
Avanafil—Hypertension—Methylprednisolone—psoriatic arthritis	0.000801	0.00431	CcSEcCtD
Avanafil—Myalgia—Triamcinolone—psoriatic arthritis	0.000792	0.00426	CcSEcCtD
Avanafil—Myalgia—Methylprednisolone—psoriatic arthritis	0.00079	0.00425	CcSEcCtD
Avanafil—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00079	0.00425	CcSEcCtD
Avanafil—Eye disorder—Prednisone—psoriatic arthritis	0.000789	0.00424	CcSEcCtD
Avanafil—Infestation—Methotrexate—psoriatic arthritis	0.000786	0.00423	CcSEcCtD
Avanafil—Infestation NOS—Methotrexate—psoriatic arthritis	0.000786	0.00423	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000785	0.00422	CcSEcCtD
Avanafil—Flushing—Prednisone—psoriatic arthritis	0.000784	0.00422	CcSEcCtD
Avanafil—Dry mouth—Triamcinolone—psoriatic arthritis	0.000775	0.00417	CcSEcCtD
Avanafil—Angiopathy—Prednisone—psoriatic arthritis	0.000766	0.00412	CcSEcCtD
Avanafil—Immune system disorder—Prednisone—psoriatic arthritis	0.000763	0.0041	CcSEcCtD
Avanafil—Vertigo—Dexamethasone—psoriatic arthritis	0.000758	0.00408	CcSEcCtD
Avanafil—Vertigo—Betamethasone—psoriatic arthritis	0.000758	0.00408	CcSEcCtD
Avanafil—Infection—Triamcinolone—psoriatic arthritis	0.000754	0.00406	CcSEcCtD
Avanafil—Infection—Methylprednisolone—psoriatic arthritis	0.000753	0.00405	CcSEcCtD
Avanafil—Haematuria—Methotrexate—psoriatic arthritis	0.000749	0.00403	CcSEcCtD
Avanafil—Insomnia—Prednisolone—psoriatic arthritis	0.000747	0.00402	CcSEcCtD
Avanafil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000743	0.004	CcSEcCtD
Avanafil—Epistaxis—Methotrexate—psoriatic arthritis	0.000741	0.00399	CcSEcCtD
Avanafil—Tachycardia—Triamcinolone—psoriatic arthritis	0.000741	0.00399	CcSEcCtD
Avanafil—Mental disorder—Prednisone—psoriatic arthritis	0.00074	0.00398	CcSEcCtD
Avanafil—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000739	0.00398	CcSEcCtD
Avanafil—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000736	0.00396	CcSEcCtD
Avanafil—Malnutrition—Prednisone—psoriatic arthritis	0.000735	0.00395	CcSEcCtD
Avanafil—Hypertension—Dexamethasone—psoriatic arthritis	0.000729	0.00392	CcSEcCtD
Avanafil—Hypertension—Betamethasone—psoriatic arthritis	0.000729	0.00392	CcSEcCtD
Avanafil—Myalgia—Dexamethasone—psoriatic arthritis	0.000719	0.00387	CcSEcCtD
Avanafil—Myalgia—Betamethasone—psoriatic arthritis	0.000719	0.00387	CcSEcCtD
Avanafil—Hypotension—Methylprednisolone—psoriatic arthritis	0.000708	0.00381	CcSEcCtD
Avanafil—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000697	0.00375	CcSEcCtD
Avanafil—Vision blurred—Prednisone—psoriatic arthritis	0.000693	0.00373	CcSEcCtD
Avanafil—Urethral disorder—Methotrexate—psoriatic arthritis	0.000692	0.00372	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000692	0.00372	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00069	0.00371	CcSEcCtD
Avanafil—Insomnia—Triamcinolone—psoriatic arthritis	0.000687	0.00369	CcSEcCtD
Avanafil—Insomnia—Methylprednisolone—psoriatic arthritis	0.000685	0.00369	CcSEcCtD
Avanafil—Infection—Betamethasone—psoriatic arthritis	0.000684	0.00368	CcSEcCtD
Avanafil—Infection—Dexamethasone—psoriatic arthritis	0.000684	0.00368	CcSEcCtD
Avanafil—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000676	0.00363	CcSEcCtD
Avanafil—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000676	0.00363	CcSEcCtD
Avanafil—Agitation—Prednisone—psoriatic arthritis	0.000675	0.00363	CcSEcCtD
Avanafil—Tachycardia—Betamethasone—psoriatic arthritis	0.000672	0.00362	CcSEcCtD
Avanafil—Tachycardia—Dexamethasone—psoriatic arthritis	0.000672	0.00362	CcSEcCtD
Avanafil—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000668	0.00359	CcSEcCtD
Avanafil—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000667	0.00359	CcSEcCtD
Avanafil—Vertigo—Prednisone—psoriatic arthritis	0.00066	0.00355	CcSEcCtD
Avanafil—Eye disorder—Methotrexate—psoriatic arthritis	0.000659	0.00355	CcSEcCtD
Avanafil—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000655	0.00352	CcSEcCtD
Avanafil—Fatigue—Triamcinolone—psoriatic arthritis	0.000655	0.00352	CcSEcCtD
Avanafil—Fatigue—Methylprednisolone—psoriatic arthritis	0.000653	0.00351	CcSEcCtD
Avanafil—Hypotension—Betamethasone—psoriatic arthritis	0.000644	0.00346	CcSEcCtD
Avanafil—Hypotension—Dexamethasone—psoriatic arthritis	0.000644	0.00346	CcSEcCtD
Avanafil—Angiopathy—Methotrexate—psoriatic arthritis	0.00064	0.00344	CcSEcCtD
Avanafil—Immune system disorder—Methotrexate—psoriatic arthritis	0.000637	0.00343	CcSEcCtD
Avanafil—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000636	0.00342	CcSEcCtD
Avanafil—Hypertension—Prednisone—psoriatic arthritis	0.000635	0.00341	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000628	0.00338	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000628	0.00338	CcSEcCtD
Avanafil—Myalgia—Prednisone—psoriatic arthritis	0.000626	0.00337	CcSEcCtD
Avanafil—Arthralgia—Prednisone—psoriatic arthritis	0.000626	0.00337	CcSEcCtD
Avanafil—Insomnia—Dexamethasone—psoriatic arthritis	0.000623	0.00335	CcSEcCtD
Avanafil—Insomnia—Betamethasone—psoriatic arthritis	0.000623	0.00335	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000621	0.00334	CcSEcCtD
Avanafil—Mental disorder—Methotrexate—psoriatic arthritis	0.000618	0.00333	CcSEcCtD
Avanafil—Malnutrition—Methotrexate—psoriatic arthritis	0.000614	0.0033	CcSEcCtD
Avanafil—Dyspepsia—Betamethasone—psoriatic arthritis	0.000606	0.00326	CcSEcCtD
Avanafil—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000606	0.00326	CcSEcCtD
Avanafil—Body temperature increased—Triamcinolone—psoriatic arthritis	0.0006	0.00323	CcSEcCtD
Avanafil—Infection—Prednisone—psoriatic arthritis	0.000596	0.00321	CcSEcCtD
Avanafil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000595	0.0032	CcSEcCtD
Avanafil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000595	0.0032	CcSEcCtD
Avanafil—Back pain—Methotrexate—psoriatic arthritis	0.000594	0.0032	CcSEcCtD
Avanafil—Fatigue—Dexamethasone—psoriatic arthritis	0.000594	0.00319	CcSEcCtD
Avanafil—Fatigue—Betamethasone—psoriatic arthritis	0.000594	0.00319	CcSEcCtD
Avanafil—Nervous system disorder—Prednisone—psoriatic arthritis	0.000588	0.00316	CcSEcCtD
Avanafil—Tachycardia—Prednisone—psoriatic arthritis	0.000585	0.00315	CcSEcCtD
Avanafil—Skin disorder—Prednisone—psoriatic arthritis	0.000583	0.00313	CcSEcCtD
Avanafil—Vision blurred—Methotrexate—psoriatic arthritis	0.000579	0.00311	CcSEcCtD
Avanafil—Vertigo—Methotrexate—psoriatic arthritis	0.000552	0.00297	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000547	0.00294	CcSEcCtD
Avanafil—Dizziness—Prednisolone—psoriatic arthritis	0.000546	0.00294	CcSEcCtD
Avanafil—Asthenia—Triamcinolone—psoriatic arthritis	0.000545	0.00293	CcSEcCtD
Avanafil—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000545	0.00293	CcSEcCtD
Avanafil—Body temperature increased—Betamethasone—psoriatic arthritis	0.000545	0.00293	CcSEcCtD
Avanafil—Asthenia—Methylprednisolone—psoriatic arthritis	0.000543	0.00292	CcSEcCtD
Avanafil—Insomnia—Prednisone—psoriatic arthritis	0.000543	0.00292	CcSEcCtD
Avanafil—Pruritus—Triamcinolone—psoriatic arthritis	0.000537	0.00289	CcSEcCtD
Avanafil—Cough—Methotrexate—psoriatic arthritis	0.000536	0.00288	CcSEcCtD
Avanafil—Pruritus—Methylprednisolone—psoriatic arthritis	0.000536	0.00288	CcSEcCtD
Avanafil—Dyspepsia—Prednisone—psoriatic arthritis	0.000528	0.00284	CcSEcCtD
Avanafil—Arthralgia—Methotrexate—psoriatic arthritis	0.000523	0.00281	CcSEcCtD
Avanafil—Chest pain—Methotrexate—psoriatic arthritis	0.000523	0.00281	CcSEcCtD
Avanafil—Myalgia—Methotrexate—psoriatic arthritis	0.000523	0.00281	CcSEcCtD
Avanafil—Rash—Prednisolone—psoriatic arthritis	0.000521	0.0028	CcSEcCtD
Avanafil—Dermatitis—Prednisolone—psoriatic arthritis	0.00052	0.0028	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000519	0.00279	CcSEcCtD
Avanafil—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000518	0.00279	CcSEcCtD
Avanafil—Fatigue—Prednisone—psoriatic arthritis	0.000517	0.00278	CcSEcCtD
Avanafil—Headache—Prednisolone—psoriatic arthritis	0.000517	0.00278	CcSEcCtD
Avanafil—Constipation—Prednisone—psoriatic arthritis	0.000513	0.00276	CcSEcCtD
Avanafil—Dizziness—Triamcinolone—psoriatic arthritis	0.000502	0.0027	CcSEcCtD
Avanafil—Dizziness—Methylprednisolone—psoriatic arthritis	0.000501	0.00269	CcSEcCtD
Avanafil—Infection—Methotrexate—psoriatic arthritis	0.000498	0.00268	CcSEcCtD
Avanafil—Asthenia—Dexamethasone—psoriatic arthritis	0.000494	0.00266	CcSEcCtD
Avanafil—Asthenia—Betamethasone—psoriatic arthritis	0.000494	0.00266	CcSEcCtD
Avanafil—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000492	0.00264	CcSEcCtD
Avanafil—Nausea—Prednisolone—psoriatic arthritis	0.00049	0.00264	CcSEcCtD
Avanafil—Pruritus—Dexamethasone—psoriatic arthritis	0.000487	0.00262	CcSEcCtD
Avanafil—Pruritus—Betamethasone—psoriatic arthritis	0.000487	0.00262	CcSEcCtD
Avanafil—Skin disorder—Methotrexate—psoriatic arthritis	0.000487	0.00262	CcSEcCtD
Avanafil—Vomiting—Triamcinolone—psoriatic arthritis	0.000483	0.0026	CcSEcCtD
Avanafil—Vomiting—Methylprednisolone—psoriatic arthritis	0.000482	0.00259	CcSEcCtD
Avanafil—Rash—Triamcinolone—psoriatic arthritis	0.000479	0.00257	CcSEcCtD
Avanafil—Dermatitis—Triamcinolone—psoriatic arthritis	0.000478	0.00257	CcSEcCtD
Avanafil—Rash—Methylprednisolone—psoriatic arthritis	0.000478	0.00257	CcSEcCtD
Avanafil—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000477	0.00257	CcSEcCtD
Avanafil—Headache—Triamcinolone—psoriatic arthritis	0.000476	0.00256	CcSEcCtD
Avanafil—Headache—Methylprednisolone—psoriatic arthritis	0.000475	0.00255	CcSEcCtD
Avanafil—Body temperature increased—Prednisone—psoriatic arthritis	0.000474	0.00255	CcSEcCtD
Avanafil—Diarrhoea—Betamethasone—psoriatic arthritis	0.000471	0.00254	CcSEcCtD
Avanafil—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000471	0.00254	CcSEcCtD
Avanafil—Hypotension—Methotrexate—psoriatic arthritis	0.000468	0.00252	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000457	0.00246	CcSEcCtD
Avanafil—Dizziness—Dexamethasone—psoriatic arthritis	0.000456	0.00245	CcSEcCtD
Avanafil—Dizziness—Betamethasone—psoriatic arthritis	0.000456	0.00245	CcSEcCtD
Avanafil—Insomnia—Methotrexate—psoriatic arthritis	0.000453	0.00244	CcSEcCtD
Avanafil—Nausea—Triamcinolone—psoriatic arthritis	0.000451	0.00243	CcSEcCtD
Avanafil—Nausea—Methylprednisolone—psoriatic arthritis	0.00045	0.00242	CcSEcCtD
Avanafil—Somnolence—Methotrexate—psoriatic arthritis	0.000446	0.0024	CcSEcCtD
Avanafil—Dyspepsia—Methotrexate—psoriatic arthritis	0.000441	0.00237	CcSEcCtD
Avanafil—Vomiting—Betamethasone—psoriatic arthritis	0.000438	0.00236	CcSEcCtD
Avanafil—Vomiting—Dexamethasone—psoriatic arthritis	0.000438	0.00236	CcSEcCtD
Avanafil—Rash—Dexamethasone—psoriatic arthritis	0.000434	0.00234	CcSEcCtD
Avanafil—Rash—Betamethasone—psoriatic arthritis	0.000434	0.00234	CcSEcCtD
Avanafil—Dermatitis—Betamethasone—psoriatic arthritis	0.000434	0.00233	CcSEcCtD
Avanafil—Dermatitis—Dexamethasone—psoriatic arthritis	0.000434	0.00233	CcSEcCtD
Avanafil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000433	0.00233	CcSEcCtD
Avanafil—Fatigue—Methotrexate—psoriatic arthritis	0.000432	0.00233	CcSEcCtD
Avanafil—Headache—Dexamethasone—psoriatic arthritis	0.000432	0.00232	CcSEcCtD
Avanafil—Headache—Betamethasone—psoriatic arthritis	0.000432	0.00232	CcSEcCtD
Avanafil—Asthenia—Prednisone—psoriatic arthritis	0.00043	0.00232	CcSEcCtD
Avanafil—Pruritus—Prednisone—psoriatic arthritis	0.000424	0.00228	CcSEcCtD
Avanafil—Diarrhoea—Prednisone—psoriatic arthritis	0.00041	0.00221	CcSEcCtD
Avanafil—Nausea—Betamethasone—psoriatic arthritis	0.000409	0.0022	CcSEcCtD
Avanafil—Nausea—Dexamethasone—psoriatic arthritis	0.000409	0.0022	CcSEcCtD
Avanafil—Dizziness—Prednisone—psoriatic arthritis	0.000397	0.00213	CcSEcCtD
Avanafil—Body temperature increased—Methotrexate—psoriatic arthritis	0.000396	0.00213	CcSEcCtD
Avanafil—Vomiting—Prednisone—psoriatic arthritis	0.000381	0.00205	CcSEcCtD
Avanafil—Rash—Prednisone—psoriatic arthritis	0.000378	0.00203	CcSEcCtD
Avanafil—Dermatitis—Prednisone—psoriatic arthritis	0.000378	0.00203	CcSEcCtD
Avanafil—Headache—Prednisone—psoriatic arthritis	0.000376	0.00202	CcSEcCtD
Avanafil—Asthenia—Methotrexate—psoriatic arthritis	0.00036	0.00193	CcSEcCtD
Avanafil—Nausea—Prednisone—psoriatic arthritis	0.000356	0.00192	CcSEcCtD
Avanafil—Pruritus—Methotrexate—psoriatic arthritis	0.000355	0.00191	CcSEcCtD
Avanafil—Diarrhoea—Methotrexate—psoriatic arthritis	0.000343	0.00185	CcSEcCtD
Avanafil—Dizziness—Methotrexate—psoriatic arthritis	0.000332	0.00178	CcSEcCtD
Avanafil—Vomiting—Methotrexate—psoriatic arthritis	0.000319	0.00171	CcSEcCtD
Avanafil—Rash—Methotrexate—psoriatic arthritis	0.000316	0.0017	CcSEcCtD
Avanafil—Dermatitis—Methotrexate—psoriatic arthritis	0.000316	0.0017	CcSEcCtD
Avanafil—Headache—Methotrexate—psoriatic arthritis	0.000314	0.00169	CcSEcCtD
Avanafil—Nausea—Methotrexate—psoriatic arthritis	0.000298	0.0016	CcSEcCtD
